Clinical Trials Browser

Phase 2 × WW Domain-Containing Oxidoreductase × Lymphoid × Clear all

NCT00063713 2008-02-11

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Completed

Lymphoma, Mantle-Cell